✦ LIBER ✦

Canagliflozin, a Novel SGLT2 Inhibitor for Treatment of Type 2 Diabetes

✍ Scribed by Nigro, S. C.; Riche, D. M.; Pheng, M.; Baker, W. L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Canagliflozin: SGLT2 inhibitor for treat

✍ Donnelly, Richard 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) ⚖ 229 KB

Inhibition of SGLT2: A Novel Strategy fo

✍ List, J F; Pfister, M; Whaley, J M; Zhang, L 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 282 KB

SGLT2 inhibitors: a promising new therap

✍ Monika Misra 📂 Article 📅 2012 🏛 Pharmaceutical Press 🌐 English ⚖ 337 KB

SGLT2 versus DPP4 inhibitors for type 2

✍ Scheen, André J 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 53 KB

SGLT2 inhibition — a novel strategy for

✍ Chao, Edward C.; Henry, Robert R. 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 587 KB

Canagliflozin, an inhibitor of sodium–gl

✍ Lamos, Elizabeth M; Younk, Lisa M; Davis, Stephen N 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 473 KB